Abstract
There has been a dramatic increase in the incidence of diabetes worldwide,
which has been exacerbated by the growing obesity problem across the globe.
Once thought of as primarily a childhood disease--sometimes referred to as
juvenile diabetes, now mostly Type 1 diabetes--the obesity crisis linked to
the adoption of a high-fat, high-carbohydrate, high-calorie American diet has
resulted in skyrocketing rates of diabetes, particularly Type 2 diabetes,
among adults across the world. As such, the global market for blood glucose
testing products is undergoing a significant transition driven by the advent
of new analytical technologies and developments in diabetes treatment.
Although the blood glucose testing segment of the in vitro diagnostics (IVD)
industry is mature, certain segments of the market, such as home testing
devices for diabetes management, will exhibit strong growth. What' s more,
non-invasive testing now represents a major new area for the application of
IVD testing. Additionally, direct access testing--or over-the-counter testing,
which allows consumers to order tests themselves without visiting a
doctor--has emerged as a strong force in the blood glucose testing segment.
The purpose of this TriMark Publications report is to describe the specific
market segments for blood glucose testing and diabetes management. This study
reviews all of the generally-accepted clinical analytical methods that are
currently in use today for measuring serum or plasma or whole-blood glucose
concentrations. Moreover, it examines clinical measurement devices, reagents
and supplies as utilized in hospitals, clinics, doctor' s offices and at-home
care locations.
| 
View Cart
